Results per Page:
From predicted neoantigen to T cell therapy for acute myeloid leukemia
From the Bleakley Lab, Cancer Consortium and Translational Science & Therapeutics Division
Short H2A histones, part II: a natural-born oncogene lurking in our genomes
From the Malik, Henikoff, Bleakley, and Bradley labs, Basic Sciences Division
T cells recognize novel cancer-specific antigen derived from leukemic gene fusion
From the Bleakley lab, Clinical Research Division